Personal tools
You are here: Home / About Us / Research Units

Research Units

Research activities are currently integrated into Research Units, which involve researchers from other institutions. In line with ITQB NOVA's research strategy, ITQB NOVA coordinates two research units (MOSTMICRO-ITQB and GREEN-IT) and participates in a third one (iNOVA4Health). All three research units have been graded Excellent in the 2017/2018 FCT evaluation.

Regardless of their participation in research units, ITQB NOVA Research Laboratories are organized into five Research Divisions - Chemistry, Biological Chemistry, Biology, Plant Sciences, and Technology.



mostmicro logo 2.jpg  

The Molecular, Structural and Cellular Microbiology Unit (MOSTMICRO-ITQB) aims to advance the fundamental knowledge of living organisms, with emphasis on important bacterial pathogens, towards improving human health.

Research is focused on selected microorganisms from all the three life domains, Bacteria, Archaea and Eukarya, for the study of basic Biological questions, to improve our understanding of pathogens, and to contribute to the identification and design of novel systems/proteins/compounds with therapeutic potential.

The unit is coordinated by ITQB NOVA.



green it logo 2.jpg  

The mission of the BioResources 4 Sustainability Unit (GREEN-IT) is to develop or design more sustainable biological and synthetic systems with application in food, feed, energy and the environment through the study of biological resources, ranging from complex systems like plants, bacteria and fungi, down to the level of proteins and molecules

GREEN-IT explores biological resources, using chemical and biological strategies, to address key societal challenges in agriculture, forestry and energy, ensuring environmental protection and supporting a bio-based economy.

The unit is coordinated by ITQB NOVA and also involves research groups from IGC, iBET INIAV and INSA.




inova logo.jpg  

iNOVA4Health is a translational medicine programme organizing the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals “pre-discovery”,

technological scientists involved in “preclinical development”, and clinicians involved in “early clinical and first in man clinical trials” from institutions within NOVA University of Lisbon. The programme has a strong emphasis on developing therapies to promote healthy ageing and in targeting chronic diseases that are responsible for two thirds of deaths worldwide and a major burden on healthcare systems for the future.

The unit is managed by iBET and also includes CEDOC - Center for Chronic Diseases of the NOVA Medical School, the IPOLFG, Portuguese Oncology Institute, and ITQB NOVA.


Document Actions